comparemela.com

Latest Breaking News On - Benjamin winograd - Page 1 : comparemela.com

LAVA Therapeutics Announces the Appointment of Dr Charles Morris as Chief Medical Officer

UTRECT, The Netherlands and PHILADELPHIA, Feb. 06, 2023 LAVA Therapeutics N.V. , an immuno-oncology company focused on developing its proprietary Gammabody™ platform of bispecific. | February 6, 2023

Seagen and LAVA Therapeutics Ink $700M+ Deal for EGFR Solid Tumor Platform

LAVA Therapeutics Provides Business Update and Reports Second Quarter Financial Results

13.09.2022 - Initial Phase 1/2a clinical findings for LAVA-051 in patients with chronic lymphocytic leukemia and multiple myeloma patients demonstrated encouraging anti-tumor activity and safety profile; on track to report additional clinical data in fourth .

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.